Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Contrafect (CFRX)

Contrafect (CFRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Contrafect 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 USA

P: 914-207-2300

Description:

ContraFect Corporation is a biotechnology company. The Company is focused on protein and antibody therapeutic products for life-threatening infectious diseases. Its product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia, and CF-404, a combination of mAbs for the treatment of life-threatening seasonal and pandemic varieties of influenza. ContraFect Corporation is headquartered in Yonkers, New York.

Key Statistics

Overview:

Market Capitalization, $K 84,939
Shares Outstanding, K 15,332
Annual Sales, $ 0 K
Annual Net Income, $ -12,790 K
60-Month Beta 1.01
% of Insider Shareholders 3.70%
% of Institutional Shareholders 37.27%
Float, K 14,765
% Float 96.30%

Growth:

1-Year Return 32.60%
3-Year Return -55.68%
5-Year Return -87.85%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 104.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/14/20
Earnings Per Share ttm -0.31
EPS Growth vs. Prev Qtr -155.68%
EPS Growth vs. Prev Year -132.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 02/04/20

CFRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -5.54
Price/Earnings to Growth N/A
Return-on-Equity % -128.80%
Return-on-Assets % -48.48%
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.37
Price/Sales N/A
Price/Cash Flow 8.94
Price/Book 9.81
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar